News

Article

Pharmaceutical Technology

Pharmaceutical Technology-05-02-2002
Volume26
Issue 5

Forced Degradation of Ibuprofen in Bulk Drug and Tablets and Determination of Specificity, Selectivity, and the Stability-Indicating Nature of the USP Ibuprofen Assay Method

Author(s):

Ranga Velagaleti, PhD

The authors subjected ibuprofen bulk drug and tablet assay preparations to various stresses to evaluate the selectivity and specificity of the drug substance and product samples.

External Link - article-18597.pdf

Articles in this issue
Direct Compression: Microcrystalline Cellulose Grade 12 versus Classic Grade 102
Harmonizing Standards and Specifications
Polymers in Transdermal Drug Delivery Systems
The Pharmaceutical Development of Inhalation Medicines and the Value of Outsourcing
Expanding the Use of Child-Resistant Packaging
Forced Degradation of Ibuprofen in Bulk Drug and Tablets and Determination of Specificity, Selectivity, and the Stability-Indicating Nature of the USP Ibuprofen Assay Method
Outsourcing Outlook
Analytical Data Management and Archiving: 21 CFR Part 11 Compliance and Beyond
E-Procurement — Reverse Auctions and the Supplier's Perspective

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
Related Content
Magnifier with pills on blue background | Image Credit: © Pixel-Shot - stock.adobe.com
July 23rd 2025

Overcoming PK/PD Modeling Challenges

Cynthia A. Challener
Artificial intelligence and machine learning can help identify complex patterns.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Image Credit: © Alessandro Grandini - stock.adobe.com
May 7th 2025

Understanding the Variability in Bioburden Test Results in Biomanufacturing

Naveenganesh Muralidharan
This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Unidentified microbiologist is place the petri dish and tubes into incubator to incubate the culture of bacteria or fungi growth in appropriate condition, concept of microbial laboratory. | Image Credit: © Sukjai Photo – © Sukjai Photo – Stock.Adobe.com
May 6th 2025

Evolving Cleanroom Procedures and Sterility Challenges

Feliza Mirasol
The shift toward personalized medicines poses new challenges in cleanroom protocols.
Macro view on vials | Image Credit: © yuriygolub - stock.adobe.com
April 5th 2025

Extractable and Leachable Challenges in Lyophilized Drug Products

Alan Xu Piet Christiaens
The authors examine the risks of extractables and leachables, and present solutions that emphasize the importance of a strategic, multi-prong approach.
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com
March 28th 2025

Beckman Coulter Life Sciences Launches Modular Spectral Flow Cytometry Module, First of Its Kind in Industry

Feliza Mirasol
The CytoFLEX mosaic Spectral Detection Module offers up to 88 channels for detection.